Imatinib is a small molecule kinase inhibitor used to treat certain types of cancer. It is occasionally referred to as CGP57148B or STI571. It is used in treating chronic myelogenous leukemia, gastrointestinal stromal tumors and a number of other malignancies. Reference standards of Imatinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => N-(4-Methyl-3-(nitroso(4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide [catalogue_number] => PA 09 0051007 [category_ids] => ,70,75,76,78,82,162, [chemical_name] => [weight] => 522.61 [form] => C29H30N8O2 [cas] => NA [pslug] => n-4-methyl-3-nitroso-4-pyridin-3-yl-pyrimidin-2-yl-amino-phenyl-4-4-methylpiperazin-1-yl-methyl-benzamide-pa090051007 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 09 0051007
CAS :
Molecular Formula : C29H30N8O2
Molecular Weight : 522.61
stdClass Object ( [pname] => N-(4-Methyl-3-(nitroso(4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide Acetate [catalogue_number] => PA 09 0051013 [category_ids] => ,70,75,76,78,82,162, [chemical_name] => [weight] => 582.67 [form] => C31H34N8O4 [cas] => NA [pslug] => n-4-methyl-3-nitroso-4-pyridin-3-yl-pyrimidin-2-yl-amino-phenyl-4-4-methylpiperazin-1-yl-methyl-benzamide-acetate-pa090051013 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 09 0051013
Molecular Formula : C31H34N8O4
Molecular Weight : 582.67
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
